Fennec Pharmaceuticals (FRX) Insider Trading & Ownership C$5.65 -0.45 (-7.38%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Fennec Pharmaceuticals (TSE:FRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)C$51,332.82Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)C$458,110.42 Get FRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Fennec Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FRX Insider Buying and Selling by Quarter Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now Fennec Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/8/2024Chris Anigeron RallisDirectorSell1,406C$6.16C$8,662.0810/2/2024Rostislav Christov RaykovDirectorSell2,431C$6.67C$16,212.349/4/2024Rostislav Christov RaykovDirectorSell2,431C$7.45C$18,115.817/5/2024Chris Anigeron RallisDirectorSell1,173C$6.03C$7,073.197/1/2024Rostislav Christov RaykovDirectorSell2,431C$6.13C$14,902.034/23/2024Adrian J. HaighSenior OfficerSell22,223C$9.32C$207,029.47 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/15/2024Adrian J. HaighSenior OfficerBuy22,222C$2.31C$51,332.824/15/2024Chris Anigeron RallisDirectorSell800C$10.45C$8,360.003/26/2024Chris Anigeron RallisDirectorSell2,114C$10.97C$23,190.583/26/2024Robert Christopher AndradeSenior OfficerSell13,975C$10.90C$152,345.6711/24/2023Chris Anigeron RallisDirectorSell269C$8.25C$2,219.25 (Data available from 1/1/2013 forward) FRX Insider Trading Activity - Frequently Asked Questions Who is on Fennec Pharmaceuticals's Insider Roster? The list of insiders at Fennec Pharmaceuticals includes Adrian J. Haigh, Chris Anigeron Rallis, Khalid Islam, Robert Christopher Andrade, and Rostislav Christov Raykov. Learn more on insiders at FRX. What percentage of Fennec Pharmaceuticals stock is owned by insiders? 16.20% of Fennec Pharmaceuticals stock is owned by insiders. Learn more on FRX's insider holdings. Which Fennec Pharmaceuticals insiders have been buying company stock? The following insiders have purchased FRX shares in the last 24 months: Adrian J. Haigh (C$51,332.82), Khalid Islam (C$50,000.48), and Rostislav Christov Raykov (C$118,920.87). How much insider buying is happening at Fennec Pharmaceuticals? Insiders have purchased a total of 117,507 FRX shares in the last 24 months for a total of C$220,254.17 bought. Which Fennec Pharmaceuticals insiders have been selling company stock? The following insiders have sold FRX shares in the last 24 months: Adrian J. Haigh (C$207,029.47), Chris Anigeron Rallis (C$60,683.24), Robert Christopher Andrade (C$152,345.67), and Rostislav Christov Raykov (C$49,230.18). How much insider selling is happening at Fennec Pharmaceuticals? Insiders have sold a total of 50,502 Fennec Pharmaceuticals shares in the last 24 months for a total of C$469,288.55 sold. Fennec Pharmaceuticals Key ExecutivesMr. Rostislav Raykov (Age 48)CEO & Director Compensation: $1.2MMr. Robert C. Andrade (Age 49)Chief Financial Officer Compensation: $817.74kMr. Adrian J. Haigh (Age 65)Chief Operating Officer Compensation: $886.92kMr. Mark GowlandControllerMr. Lei FangPresident of Pharstat Inc More Insider Trading Tools from MarketBeat Related Companies SLS Insider Buying APM Insider Buying GXE Insider Buying MDNA Insider Buying ME Insider Buying CGC Insider Buying RGC Insider Buying ASND Insider Buying NBY Insider Buying GRI Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (TSE:FRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
